8 months ago
ARGX
AnalystsAllison BratzelAllison Bratzel's Stock Forecasts
AnalystsAllison Bratzel
Sectors:
Industries:
Analyst Ranking
Top 31%
#1391 out of 4560 analysts
Average Return
+4.06%
Win Rate
44%8 out of 18
Risk vs Reward
Poor
Good
Allison Bratzel's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +86.26% | $8.44 | $15.72 | 2023-04-02 - 2024-04-02 | Strong Buy |
Vectivbio Holding AgVECT | +77.37% | $9.50 | $16.85 | 2023-04-19 - 2023-07-07 | Strong Buy |
Argenx SeARGX | +43.42% | $363.61 | $521.49 | 2022-07-24 - 2023-07-24 | Strong Buy |
Argenx SeARGX | +32.01% | $384.12 | $507.07 | 2022-08-25 - 2023-08-25 | Strong Buy |
Argenx SeARGX | +24.41% | $323.10 | $401.96 | 2022-05-26 - 2023-05-26 | Strong Buy |
Allison Bratzel Analyst Color
Get additional color on Allison Bratzel's coverage of popular stocks
Allison Bratzel's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | 2 | Strong Buy | $28.00 | +89.32% | Maintains | a month ago |
Humacyte IncHUMA | 2 | Hold | $4.00 | +1.78% | Maintains | a month ago |
Solid Biosciences IncSLDB | 4 | Strong Buy | $20.00 | +119.54% | Upgrades | a month ago |
Argenx SeARGX | 9 | Strong Buy | $522.00 | +39.17% | Maintains | 3 months ago |
Roivant Sciences LtdROIV | 1 | Strong Buy | $20.00 | +82.82% | Initiates Coverage On | 4 months ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $20.00 | +403.78% | Assumes | 6 months ago |
Vectivbio Holding AgVECT | 1 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Replimune Group IncREPL | 1 | Strong Buy | $44.00 | N/A | Assumes | a year ago |
Rigel Pharmaceuticals IncRIGL | 1 | Hold | $2.00 | N/A | Assumes | a year ago |
Incyte CorpINCY | 2 | Strong Buy | $100.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.